These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 85367)

  • 1. [Mechanisms of the potentiating and blocking effects of the sera from tumor patients in the leukocyte migration inhibition reaction model].
    Grigor'eva MP
    Vopr Onkol; 1979; 25(1):31-8. PubMed ID: 85367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro immune response of patient lymphocytes to live autologous tumor cells].
    Grigor'eva MP; Kosmiadi GA; Govallo VI
    Vopr Onkol; 1980; 26(9):8-11. PubMed ID: 7423909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of leukocyte migration by tumor-associated antigen and its modification by serum; IgA as a blocking factor.
    Sipos J; Gábor V; Tóth Z
    Neoplasma; 1978; 25(2):181-8. PubMed ID: 643122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Suppression of leukocyte migration by autologous and allogeneic tumor extracts in kidney cancer patients].
    Novikov DK; Borisenko ID; Shein IA
    Vopr Onkol; 1978; 24(12):50-5. PubMed ID: 83731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of leukocyte migration by tumor-associated antigen in soluble extracts of human hepatoma.
    Lee C; Chen S; Lin T
    Cancer Res; 1977 Mar; 37(3):918-21. PubMed ID: 189919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellular antitumor immunity in an autologous system in stomach cancer].
    Kurtenkov OA
    Vopr Onkol; 1981; 27(6):36-40. PubMed ID: 7269415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological studies in breast cancer. Modifying activity of the serum (MSA).
    Cervantes C; Muzio E; Exposito G; Garcia ME
    Neoplasma; 1980; 27(4):379-86. PubMed ID: 7453855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphocyte subpopulations in malignant bone tumors and their relation to the immune response to the tumor].
    Kosmiadi GA; Grigor'eva MP; Govallo VI
    Vopr Onkol; 1981; 27(2):43-7. PubMed ID: 6971012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological monitoring in lung cancer: use of the leukocyte migration inhibition assay.
    Abai AM; Fekete B
    Haematologia (Budap); 1982; 15(1):111-25. PubMed ID: 6749608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leukocyte adhesion suppression reaction for determining the immunological reactivity of oncological patients].
    Frolova LM; Govallo VI
    Vopr Onkol; 1978; 24(5):10-4. PubMed ID: 351953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cell immunity indices in carcinoma of the gastrointestinal tract].
    Kurtenkov OA
    Vopr Onkol; 1976; 22(10):14-8. PubMed ID: 1014487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common aspects of immunologic tolerance in pregnancy and malignancy.
    Gleicher N; Deppe G; Cohen CJ
    Obstet Gynecol; 1979 Sep; 54(3):335-42. PubMed ID: 382002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte migration inhibition in vitro in bladder carcinoma.
    Lavergne JA; Lamm DL; Radwin HM; Harrington JT
    Cancer Res; 1979 Jun; 39(6 Pt 1):1985-8. PubMed ID: 445398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of leukocyte migration by soluble tumor extracts in human malignant melanoma.
    Lapińska M; Jassem J; Kondrat W; Jaśkiewicz J
    Neoplasma; 1980; 27(1):37-42. PubMed ID: 6154899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development and clinical approval of a micromodification of the human leukocyte migration inhibition reaction].
    Grigor'eva MP
    Biull Eksp Biol Med; 1975 Aug; 80(8):122-5. PubMed ID: 1101982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on tumor-specific immune response evaluated by leucocyte migration inhibition test under agarose-plate in gynecological malignancy (author's transl)].
    Nakamura S
    Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1015-24. PubMed ID: 6171133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of cellular immune response to cancer of the breast.
    Herberman RB
    Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a leucocyte adherence test with the leucocyte migration inhibition test and skin reactivity to PPD.
    Bullen AW; Losowsky MS
    Clin Exp Immunol; 1978 Mar; 31(3):408-13. PubMed ID: 350459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of leukocyte migration with melanoma-associated antigens in choroidal tumors.
    Char DH
    Invest Ophthalmol Vis Sci; 1977 Feb; 16(2):176-9. PubMed ID: 832980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.